HFS
Howard Financial Services’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $550K | Buy |
2,965
+120
| +4% | +$22.3K | 0.07% | 94 |
|
2025
Q1 | $596K | Sell |
2,845
-915
| -24% | -$192K | 0.08% | 91 |
|
2024
Q4 | $668K | Buy |
3,760
+113
| +3% | +$20.1K | 0.09% | 86 |
|
2024
Q3 | $720K | Buy |
3,647
+314
| +9% | +$62K | 0.1% | 70 |
|
2024
Q2 | $572K | Buy |
3,333
+34
| +1% | +$5.83K | 0.09% | 75 |
|
2024
Q1 | $601K | Sell |
3,299
-505
| -13% | -$92K | 0.1% | 73 |
|
2023
Q4 | $590K | Buy |
3,804
+184
| +5% | +$28.5K | 0.11% | 70 |
|
2023
Q3 | $540K | Buy |
3,620
+294
| +9% | +$43.8K | 0.12% | 71 |
|
2023
Q2 | $448K | Sell |
3,326
-17
| -0.5% | -$2.29K | 0.11% | 74 |
|
2023
Q1 | $533K | Buy |
3,343
+202
| +6% | +$32.2K | 0.13% | 69 |
|
2022
Q4 | $508K | Buy |
3,141
+1,014
| +48% | +$164K | 0.13% | 70 |
|
2022
Q3 | $285K | Buy |
2,127
+314
| +17% | +$42.1K | 0.09% | 97 |
|
2022
Q2 | $278K | Buy |
1,813
+371
| +26% | +$56.9K | 0.09% | 95 |
|
2022
Q1 | $234K | Sell |
1,442
-1,650
| -53% | -$268K | 0.07% | 116 |
|
2021
Q4 | $419K | Buy |
3,092
+423
| +16% | +$57.3K | 0.13% | 66 |
|
2021
Q3 | $288K | Sell |
2,669
-1,479
| -36% | -$160K | 0.11% | 90 |
|
2021
Q2 | $467K | Buy |
4,148
+752
| +22% | +$84.7K | 0.18% | 63 |
|
2021
Q1 | $368K | Buy |
3,396
+91
| +3% | +$9.86K | 0.17% | 71 |
|
2020
Q4 | $354K | Buy |
+3,305
| New | +$354K | 0.19% | 62 |
|